We’re a leading bioscience company focused on accelerating new and innovative medical solutions for positive impact.
Stay up to date. Find out about our latest research, products, exclusive partnerships and more.
XPhyto brings together cutting-edge companies and top researchers from around the world to innovate, accelerate and commercialize disruptive technology, from drug delivery formulations to diagnostics.
Innovative and Cutting-Edge Solutions
Precision transdermal and oral drug formulations
Point-of-care (POC) diagnostics including rapid infectious disease screening
Production, formulation and validation of new active pharmaceutical ingredients (APIs)
Our research and innovation have the potential to impact lives around the world.
Learn more about how XPhyto products could change the lives of people suffering from conditions and how our new research may impact the state of our global community.
Jun 8, 2021
Research and development lab set up, preliminary mescaline synthesis completeModified synthesis process developed, mescaline batches manufacturedDevelopment of analytical methods and validation, GMP standard operating procedures...
Featured, News, Press Releases
May 20, 2021
Rapid 25-minute point-of-care COVID-19 PCR test available for purchase in Germany commencing May 25, 2021Volume based pricing competitive with other COVID-19 PCR test products on...
May 13, 2021
Rotigotine transdermal human pilot study successfully completed; program advancing to pivotal studyLand purchased for construction of commercial drug manufacturing facility in Germany Vancouver, Canada, and...
Learn more about XPhyto’s innovation to impact strategy and get access to XPhyto investor information.
CSE:XPHY FSE:4XT OTCQB:XPHYF
